Literature DB >> 9930667

Domain swapping in G-protein coupled receptor dimers.

P R Gouldson1, C R Snell, R P Bywater, C Higgs, C A Reynolds.   

Abstract

Computer simulations were performed on models of the beta2-adrenergic receptor dimer, including 5,6-domain swapped dimers which have been proposed as the active, high affinity form (here the dimer interface lies between helices 5 and 6). The calculations suggest that the domain swapped dimer is a high energy structure in both the apo dimer and in the presence of propranolol. In the presence of agonist the energy of the domain swapped dimer is significantly lowered. Analysis of the dimer structure suggests that the agonist-induced conformational change optimizes the helix-helix interactions at the 5-6 interface. An antagonist on the other hand has little effect on these interactions. These observations are consistent with the hypothesis that the agonist functions by shifting the equilibrium in favour of the domain swapped dimer. Indirect support for the domain swapping hypothesis was obtained from the correlated mutations amongst the external residues of the known beta2-adrenergic receptors. These occur mainly at the 5-6 interface at precisely the locations predicted by the simulations; site-directed mutagenesis data in support of a functional role for these lipid-facing correlated residues is presented. The article includes a review of the experimental evidence for G-protein coupled receptor dimerization. Many other aspects of G-protein coupled receptor activation are discussed in terms of this domain swapping hypothesis

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930667     DOI: 10.1093/protein/11.12.1181

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  18 in total

1.  G-protein-coupled receptor heterodimerization modulates receptor function.

Authors:  B A Jordan; L A Devi
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

2.  Molecular mechanism of domain swapping in proteins: an analysis of slower motions.

Authors:  Sibsankar Kundu; Robert L Jernigan
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

Review 3.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

Review 4.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 5.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

Review 7.  Synthetic multivalent ligands as probes of signal transduction.

Authors:  Laura L Kiessling; Jason E Gestwicki; Laura E Strong
Journal:  Angew Chem Int Ed Engl       Date:  2006-04-03       Impact factor: 15.336

8.  Transmembrane domains of attraction on the TSH receptor.

Authors:  Rauf Latif; M Rejwan Ali; Mihaly Mezei; Terry F Davies
Journal:  Endocrinology       Date:  2014-11-19       Impact factor: 4.736

Review 9.  Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases.

Authors:  Luigi Francesco Agnati; Sergi Ferre; Raffaella Burioni; Amina Woods; Susanna Genedani; Rafael Franco; Kjell Fuxe
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 10.  Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.

Authors:  Tim D Werry; Graeme F Wilkinson; Gary B Willars
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.